Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder

Attention-deficit/hyperactivity disorder (ADHD) is a common, highly heritable neurodevelopmental disorder. Genetic loci have not yet been identified by genome-wide association studies. Rare copy number variations (CNVs), such as chromosomal deletions or duplications, have been implicated in ADHD and other neurodevelopmental disorders. To identify rare (frequency ⩽1%) CNVs that increase the risk of ADHD, we performed a whole-genome CNV analysis based on 489 young ADHD patients and 1285 adult population-based controls and identified one significantly associated CNV region. In tests for a global burden of large (>500 kb) rare CNVs, we observed a nonsignificant (P=0.271) 1.126-fold enriched rate of subjects carrying at least one such CNV in the group of ADHD cases. Locus-specific tests of association were used to assess if there were more rare CNVs in cases compared with controls. Detected CNVs, which were significantly enriched in the ADHD group, were validated by quantitative (q)PCR. Findings were replicated in an independent sample of 386 young patients with ADHD and 781 young population-based healthy controls. We identified rare CNVs within the parkinson protein 2 gene (PARK2) with a significantly higher prevalence in ADHD patients than in controls (P=2.8 × 10−4 after empirical correction for genome-wide testing). In total, the PARK2 locus (chr 6: 162 659 756–162 767 019) harboured three deletions and nine duplications in the ADHD patients and two deletions and two duplications in the controls. By qPCR analysis, we validated 11 of the 12 CNVs in ADHD patients (P=1.2 × 10−3 after empirical correction for genome-wide testing). In the replication sample, CNVs at the PARK2 locus were found in four additional ADHD patients and one additional control (P=4.3 × 10−2). Our results suggest that copy number variants at the PARK2 locus contribute to the genetic susceptibility of ADHD. Mutations and CNVs in PARK2 are known to be associated with Parkinson disease.

[1]  Christine Van Broeckhoven,et al.  Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes , 2011, Journal of Chemical Neuroanatomy.

[2]  W. Ondo,et al.  Family‐based and population‐based association studies validate PTPRD as a risk factor for restless legs syndrome , 2011, Movement disorders : official journal of the Movement Disorder Society.

[3]  M. Owen,et al.  Clinical and cognitive characteristics of children with attention-deficit hyperactivity disorder, with and without copy number variants , 2011, British Journal of Psychiatry.

[4]  K. Lange,et al.  Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood. , 2007, Journal of neural transmission. Supplementum.

[5]  Rebecca F. Halperin,et al.  Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12 , 2008, Molecular Psychiatry.

[6]  G. Kirov,et al.  Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. , 2009, Human molecular genetics.

[7]  John Wei,et al.  Identify Risk Genes for ADHD Rare Copy Number Variation Discovery and Cross-Disorder Comparisons , 2011 .

[8]  Carlos S. Moreno,et al.  Relative Burden of Large CNVs on a Range of Neurodevelopmental Phenotypes , 2011, PLoS genetics.

[9]  M. Gill,et al.  Investigating the Contribution of Common Genetic Variants to the Risk and Pathogenesis of ADHD , 2012, The American journal of psychiatry.

[10]  B. Herpertz-Dahlmann,et al.  Molecular genetic aspects of attention-deficit/hyperactivity disorder , 2004, Neuroscience & Biobehavioral Reviews.

[11]  K. Lesch,et al.  Allelic variants of SNAP25 in a family-based sample of ADHD , 2008, Journal of Neural Transmission.

[12]  Joshua M. Korn,et al.  Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.

[13]  P. Stankiewicz,et al.  Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities , 2008, Nature Genetics.

[14]  B. Oostra,et al.  Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil , 2006, Neurogenetics.

[15]  C. Freitag,et al.  Phenotypic and measurement influences on heritability estimates in childhood ADHD , 2010, European Child & Adolescent Psychiatry.

[16]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[17]  Susanne Walitza,et al.  Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder , 2011, Nature Genetics.

[18]  Cisca Wijmenga,et al.  Gene-Network Analysis Identifies Susceptibility Genes Related to Glycobiology in Autism , 2009, PloS one.

[19]  C. Gieger,et al.  KORA-gen - Resource for Population Genetics, Controls and a Broad Spectrum of Disease Phenotypes , 2005 .

[20]  Susanne Walitza,et al.  Genome-Wide Analysis of Copy Number Variants in Attention Deficit Hyperactivity Disorder: The Role of Rare Variants and Duplications at 15q13.3 , 2012, The American journal of psychiatry.

[21]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[22]  P. Stankiewicz,et al.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size , 2009, Journal of Medical Genetics.

[23]  Olf Herbarth,et al.  Timing of Solid Food Introduction in Relation to Atopic Dermatitis and Atopic Sensitization: Results From a Prospective Birth Cohort Study , 2006, Pediatrics.

[24]  O. Migita,et al.  An association between a missense polymorphism in the close homologue of L1 (CHL1, CALL) gene and schizophrenia , 2002, Molecular Psychiatry.

[25]  M. Daly,et al.  Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders , 2008, Journal of Medical Genetics.

[26]  C. Freitag,et al.  No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD , 2007, Journal of Neural Transmission.

[27]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. , 2011, American journal of human genetics.

[28]  Joseph A. Gogos,et al.  Strong association of de novo copy number mutations with sporadic schizophrenia , 2008, Nature Genetics.

[29]  K Konrad,et al.  A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs , 2006, Molecular Psychiatry.

[30]  Michael Krawczak,et al.  PopGen: Population-Based Recruitment of Patients and Controls for the Analysis of Complex Genotype-Phenotype Relationships , 2006, Public Health Genomics.

[31]  C. Baker,et al.  Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. , 2010, Brain : a journal of neurology.

[32]  H. Wichmann,et al.  Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course – the GINIplus study up to the age of 6 years , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[33]  D. Porteous,et al.  NDE1 and NDEL1: Multimerisation, alternate splicing and DISC1 interaction , 2009, Neuroscience Letters.

[34]  Robert T. Schultz,et al.  Autism genome-wide copy number variation reveals ubiquitin and neuronal genes , 2009, Nature.

[35]  S. Cichon,et al.  Genome‐wide association study in German patients with attention deficit/hyperactivity disorder , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[36]  Fassnacht,et al.  Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree , 2011, Molecular Psychiatry.

[37]  Benjamin M. Neale,et al.  Genome-wide association studies in ADHD , 2009, Human Genetics.

[38]  Joshua M. Korn,et al.  Accurately Assessing the Risk of Schizophrenia Conferred by Rare Copy-Number Variation Affecting Genes with Brain Function , 2010, PLoS genetics.

[39]  O. Mayo.  The Rise and Fall of the Common Disease–Common Variant (CD–CV) Hypothesis: How the Sickle Cell Disease Paradigm Led Us All Astray (Or Did It?) , 2007, Twin Research and Human Genetics.

[40]  Fikret Erdogan,et al.  Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation , 2007, Human mutation.

[41]  H. Stefánsson,et al.  Supplementary webappendix , 2018 .

[42]  Jian Feng,et al.  Parkin Increases Dopamine Uptake by Enhancing the Cell Surface Expression of Dopamine Transporter* , 2004, Journal of Biological Chemistry.

[43]  B. Horta,et al.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.

[44]  S. Faraone,et al.  Molecular genetics of attention deficit hyperactivity disorder. , 2010, The Psychiatric clinics of North America.

[45]  Jemma B. Wilk,et al.  Copy Number Variation in Familial Parkinson Disease , 2011, PloS one.